Company page

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. is a public company traded under the ticker APLS in the American market. With a market capitalization of approximately $5.25 billion, Apellis focuses on developing innovative therapies to address unmet medical needs. The company is dedicated to advancing treatments that improve patient outcomes.